KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Procter & Gamble (PG) EPS (Weighted Average and Diluted) (2016 - 2026)

Procter & Gamble has reported EPS (Weighted Average and Diluted) over the past 18 years, most recently at $1.63 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 5.84% to $1.63 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.84 through Mar 2026, up 8.57% year-over-year, with the annual reading at $6.51 for FY2025, 8.14% up from the prior year.
  • EPS (Weighted Average and Diluted) was $1.63 for Q1 2026 at Procter & Gamble, down from $1.78 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $1.95 in Q3 2025 and troughed at $1.22 in Q2 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is $1.54 (2025), against an average of $1.55.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 34.29% in 2024 against a maximum downside of 12.02% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.59 in 2022, then fell by 11.95% to $1.4 in 2023, then surged by 34.29% to $1.88 in 2024, then fell by 5.32% to $1.78 in 2025, then dropped by 8.43% to $1.63 in 2026.
  • Per Business Quant, the three most recent readings for PG's EPS (Weighted Average and Diluted) are $1.63 (Q1 2026), $1.78 (Q4 2025), and $1.95 (Q3 2025).